These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31012144)

  • 1. Synthesis of novel gefitinib-based derivatives and their anticancer activity.
    Sharma MJ; Kumar MS; Murahari M; Mayur YC
    Arch Pharm (Weinheim); 2019 May; 352(5):e1800381. PubMed ID: 31012144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis,
    Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G
    Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers.
    Wang C; Xu S; Peng L; Zhang B; Zhang H; Hu Y; Zheng P; Zhu W
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):203-217. PubMed ID: 30835140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors.
    Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Firdaus JU; Rahman S; Jha M; Sheikh AA
    Anticancer Agents Med Chem; 2021; 21(1):42-60. PubMed ID: 32718297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolidino Analogues of Gefitinib with Improved EGFR Inhibition, Cancer Cell Cytotoxicity, and Pharmacokinetic Properties.
    Fang JK; Xu Z; Zhang Y; Zhang W; Liu B; Fang Y; Sun T
    Anticancer Agents Med Chem; 2016; 16(12):1665-1672. PubMed ID: 27349449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, anticancer evaluation and mechanisms of cytotoxic activity of novel 3-hydroxy-3-pyrrolin-2-ones bearing thenoyl fragment: DNA, BSA interactions and molecular docking study.
    Joksimović N; Petronijević J; Janković N; Baskić D; Popović S; Todorović D; Matić S; Bogdanović GA; Vraneš M; Tot A; Bugarčić Z
    Bioorg Chem; 2019 Jul; 88():102954. PubMed ID: 31054428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity.
    Adly ME; Gedawy EM; El-Malah AA; El-Telbany FA
    Anticancer Agents Med Chem; 2018; 18(5):747-756. PubMed ID: 29366427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
    Murahari M; Prakash KV; Peters GJ; Mayur YC
    Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anticancer potential of novel 5,6-oxygenated and/or halogenated steroidal d-homo lactones.
    Kuzminac IZ; Jakimov DS; Bekić SS; Ćelić AS; Marinović MA; Savić MP; Raičević VN; Kojić VV; Sakač MN
    Bioorg Med Chem; 2021 Jan; 30():115935. PubMed ID: 33340938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-
    Deng X; Tan X; An T; Ma Q; Jin Z; Wang C; Meng Q; Hu C
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30769844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
    Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
    Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antitumor activity of novel pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors.
    Abdelgawad MA; Bakr RB; Alkhoja OA; Mohamed WR
    Bioorg Chem; 2016 Jun; 66():88-96. PubMed ID: 27043178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of anilino-furo[2,3-d]pyrimidine derivatives as dual inhibitors of EGFR/HER2 tyrosine kinase and their anticancer activity.
    Hossam M; Lasheen DS; Ismail NSM; Esmat A; Mansour AM; Singab ANB; Abouzid KAM
    Eur J Med Chem; 2018 Jan; 144():330-348. PubMed ID: 29275232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
    Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
    Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents.
    Li J; Zheng TC; Jin Y; Xu JG; Yu JG; Lv YW
    Chem Pharm Bull (Tokyo); 2018 Jan; 66(1):55-60. PubMed ID: 29118308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Efficacy of Gefitinib in Drug-Sensitive and Drug-Resistant Cancer Cell Lines after Arming with a Singlet Oxygen Releasing Moiety.
    Huang K; Huo B; Li D; Xue J; Chen J
    ChemMedChem; 2020 May; 15(9):794-798. PubMed ID: 32162481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Modeling, Docking, Dynamics and Simulation of Gefitinib and its Derivatives with EGFR in Non-small Cell Lung Cancer.
    Reddy PS; Lokhande KB; Nagar S; Reddy VD; Murthy PS; Swamy KV
    Curr Comput Aided Drug Des; 2018; 14(3):246-252. PubMed ID: 29493460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.